aid: trexbio name: TRexBio description: 'TRexBio, Inc. is a clinical-stage biotechnology company headquartered at 681 Gateway Blvd in South San Francisco, California, founded in 2018 and seed funded by SV Health Investors, that discovers and develops immunoregulatory biologics based on tissue regulatory T cell (Treg) biology. Its Deep Biology Platform combines human tissue samples, computational biology and immunobiology expertise to map how tissue Tregs behave in disease and to identify and characterize novel targets for inflammatory, autoimmune and other immune-mediated conditions. Disclosed programs include TRB-061, the CD30 agonist TRB-071, TRB-081, and the Lilly-partnered TRB-051, with Phase 1 trials expected to initiate in 2027. The company announced an $84 million Series B in November 2024 and closed a further $50 million financing in January 2026; investors include Eli Lilly and Company, Pfizer Ventures, Johnson & Johnson, SV Health Investors and Polaris Partners. TRexBio publishes no developer program, API documentation, SDK or machine-readable API contract. trex.bio is a WordPress marketing site whose only machine-readable surfaces are the WordPress core REST API, a Yoast-generated llms.txt, and an OAuth-protected WordPress MCP adapter endpoint — CMS infrastructure rather than a product API.' image: https://trex.bio/wp-content/uploads/2025/10/cropped-Group-3.png url: https://raw.githubusercontent.com/api-evangelist/trexbio/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market x-tier: profile x-tier-reason: no-api-surface specificationVersion: '0.23' created: '2026-08-05' modified: '2026-08-05' tags: - Company - Biotechnology - Life Sciences - Pharmaceuticals - Immunology - Drug Discovery - Regulatory T Cells - Clinical Stage - Computational Biology - Therapeutics - South San Francisco apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: MCPServer url: mcp/trexbio-mcp.yml - type: Website url: https://trex.bio/ - type: About url: https://trex.bio/about-trex-bio/ - type: Platform url: https://trex.bio/deep-biology-platform/ - type: Pipeline url: https://trex.bio/pipeline/ - type: Blog url: https://trex.bio/news/ - type: BlogFeeds url: https://trex.bio/feed/ - type: Research url: https://trex.bio/news/ - type: Careers url: https://trex.bio/careers/ - type: Contact url: https://trex.bio/contact-us/ - type: TermsOfService url: https://trex.bio/terms-of-use/ - type: PrivacyPolicy url: https://trex.bio/privacy-policy/ - type: CookiePolicy url: https://trex.bio/cookie-policy/ - type: LinkedIn url: https://www.linkedin.com/company/trexbio-inc/ - type: GitHubOrganization url: https://github.com/trexbio - type: Investors url: https://forgeglobal.com/trexbio_stock/ - type: LLMsTxt url: llms/trexbio-llms.txt - type: WellKnown url: well-known/trexbio-well-known.yml - type: DomainSecurity url: security/trexbio-domain-security.yml x-enrichment: date: '2026-08-05' status: minimal artifacts_added: 6 pass: local-v1 x-coverage: state: none reason: no-developer-program detail: >- TRexBio is a clinical-stage Treg biologics company with no developer program at all — trex.bio is a WordPress/WP Engine marketing site, and the only machine-readable things on it are stock CMS plumbing: the WordPress core REST API at /wp-json/ (342 routes, all of them WordPress and plugin routes), a Yoast-SEO-generated /llms.txt listing news posts and careers pages, and an undocumented WordPress MCP adapter at /wp-json/mcp/mcp-oauth-server that returns 401 mcp_unauthorized to anonymous tools/list — there is no product API, no /openapi.json, no docs host, and github.com/trexbio has zero public repositories. evidence: - url: https://trex.bio/openapi.json status: 404 - url: https://trex.bio/graphql status: 404 - url: https://trex.bio/.well-known/agent-card.json status: 404 - url: https://trex.bio/wp-json/mcp/mcp-oauth-server status: 401 - url: https://trex.bio/llms.txt status: 200 - url: https://api.github.com/orgs/trexbio/repos status: 200 checked: '2026-08-05'